Vizgen Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Employees
  • 21
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $31M
Latest Deal Amount
  • Investors
  • 6

Vizgen General Information

Description

Developer of biomolecule profiling technology intended to bring new insight into biological systems and disease. The company's technology focuses on unlocking the power of spatially resolved, single-cell gene expression profiling in intact tissue slices using spatial gene profiling measurements, enabling medical researchers to efficiently interrogate biology on a systems scale.

Contact Information

Website
www.vizgen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 37 Spinelli Place
  • West Cambridge Science Park
  • Cambridge, MA 02138
  • United States
+1 (781) 000-0000

Vizgen Timeline

20202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vizgen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 26-Mar-2021 $31M 0000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 03-Oct-2019 0000 0000 000.00 Completed Generating Revenue
To view Vizgen’s complete valuation and funding history, request access »

Vizgen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Vizgen’s complete cap table history, request access »

Vizgen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biomolecule profiling technology intended to bring new insight into biological systems and disease. The com
Biotechnology
Cambridge, MA
21 As of 2021
0000
0000 0000-00-00
00000000000 0000

00000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000000000000
San Francisco, CA
0 As of 0000
000000&0

00000000

nim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000000000000
Mountain View, CA
00 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vizgen Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Epinomics Formerly VC-backed San Francisco, CA 0 000000&0
00000000 Private Debt Financed Mountain View, CA 00 000000000 -
00000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000 Formerly VC-backed Providence, RI 00 0000 000000000 - 0000
0000000 Formerly VC-backed San Diego, CA 000 00000 000000&0 00000
You’re viewing 5 of 27 competitors. Get the full list »

Vizgen Executive Team (8)

Name Title Board Seat Contact Info
Terry Lo President, Chief Executive Officer & Board Member
Philip Gardella Chief Financial Officer
Xiaowei Zhuang Ph.D Co-Founder & Scientific Consultant
Jiang He Co-Founder & Executive Officer
George Emanuel Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Vizgen Board Members (6)

Name Representing Role Since
Andrea Jackson Northpond Ventures Board Member 000 0000
David Walt Ph.D Self Co-Founder & Board Member 000 0000
Keith Crandell ARCH Venture Partners Board Member 000 0000
Marijn Dekkers Ph.D Novalis LifeSciences Board Member 000 0000
Terry Lo Vizgen President, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Vizgen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vizgen Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novalis LifeSciences Venture Capital Minority 000 0000 000000 0
Pura Vida Investments Hedge Fund Minority 000 0000 000000 0
Tao Capital Other Minority 000 0000 000000 0
Tao Capital Partners Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »